chrisvoncsefalvay/vaers-outcomes huggingface dataset:
muscle cramp; tightness in chest; shoulders cold sweat with no fever; body weakness; 7days brain fog; This is a spontaneous report from a contactable consumer reported for himself that a 61-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8733, expiry date: Jul2021) at the age of 61-years, via an unspecified route of administration in right arm on 29Mar2021 11:30 at single dose for COVID-19 immunization. Medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient experienced 7days brain fog, muscle cramp, tightness in chest, shoulders cold sweat with no fever and body weakness. These events started since unknown date (reported as 28Mar2021, pending clarification). No treatment received for the adverse events. Outcome of the events was recovered/resolved. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
Breakthrough case after 4 vaccines Pfizer 1/26/21 Lot# EL9264;  Pfizer 2/17/21 Lot# EN6201;  Pfizer 11/24/21 Lot# 30145BA;  Moderna 9/15/22 Lot# AS7148B
Initial report was received on 29 October 2013 from a health care professional. An 11 year-old male patient with no past medical history had received an intramuscular injection of FLUZONE, lot number UH889AA (site and date of administration not reported) and two to three days later, was evaluated in the emergency department due to tachycardia. The patient was diagnosed with atrial arrhythmia and hospitalized for two to three days. Relevant diagnostic tests/ laboratory data was unknown. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: none.
Upon administration of the vaccine, pt developed significant localized swelling at administration site. Approximately the size of a marble. Pt reported no  other side effects.
right arm vaccination site is swollen; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE SWELLING (right arm vaccination site is swollen) in an elderly female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 31-Oct-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced VACCINATION SITE SWELLING (right arm vaccination site is swollen). At the time of the report, VACCINATION SITE SWELLING (right arm vaccination site is swollen) had not resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.       No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that arm was swollen the size of a Ping-Pong ball. No treatment information was provided.
BLOOD PRESSURE DROPPED; ELEVATED HEART RATE; TROUBLE BREATHING; FEVER; HEADACHE; MUSCLE SORE; This spontaneous report received from a consumer concerned a 53 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018) dose was not reported, administered on 06-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced fever. On 06-MAR-2021, the subject experienced headache. On 06-MAR-2021, the subject experienced muscle sore. On an unspecified date, the subject experienced blood pressure dropped, elevated heart rate, and trouble breathing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, headache, and muscle sore on 07-MAR-2021, and had not recovered from blood pressure dropped, elevated heart rate, and trouble breathing. This report was non-serious.
Reports nausea, vomiting, facial swelling, chest swelling, increased blood preasure, temp. Went to ETC for these symptoms, was d/c home later that evening.
4/1/2021 Patient was observed post Covid-19 immunization for 15 minutes .  During the observation period, he experienced an adverse reaction with the following symptoms:  Diaphoresis.   Assessment : Time of assessment 0920. BP_ 101/45, P- 45. SPO2- 100%, Juice and cookies given, Recheck- BP- 106/58, P- 100, SPO2- 100% Actions taken:  Vitals sign taken  VAERS form completed       Medications administered: No medication administered.   Disposition: Reports no further symptoms of adverse reaction after observation for 30 minutes. Discharged home. The Patient was provided with Vaccine Information Sheet and instruction to access the V-Safe system.      Immunizations Administered    Name Date Dose VIS Date Route   Pfizer COVID-19 Vaccine 4/1/2021  9:06 AM 0.3 mL 12/11/2020 Intramuscular   Manufacturer: Pfizer, Inc   Lot: EP7533
Peripheral neuropathy of bilateral lower extremities, ataxia; condition persists.  High fever, rash at injection site; resolved.
3 days after 2nd vaccine my son had stabbing chest pain. We was transported by ambulance from a local ER to hospital with high traponin levels.  He was diagnosed with Myocarditis from the vaccine.
Patient states that she noted a visible twitching of the left eye on Sunday, 10/25/09.  States that the twitching has occurred less frequently each day after 10/25/09.  States she only noted one time on 10/26/09.
Little bit of soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little bit of soreness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A, 014M20A and 027O21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]) for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (Little bit of soreness). The patient was treated with LYSINE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Little bit of soreness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-392147 (Patient Link).
This 74 year old woman with stage 4 CKD was admitted with acute kidney injury. She was seen by nephrology. Her Aldactone and ARB were stopped and when able her Lasix was increased. Admission creatinine was 2.7; it is at baseline of 1.9 today. She did test positive for Covid-19 and is vaccinated. No treatment required. Follow up with PCP and nephrology.
burning hot at 1 AM; looks awful; Pale; bad fever; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning hot at 1 AM), FEELING ABNORMAL (looks awful), PALLOR (Pale) and PYREXIA (bad fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced BURNING SENSATION (burning hot at 1 AM), FEELING ABNORMAL (looks awful), PALLOR (Pale) and PYREXIA (bad fever). At the time of the report, BURNING SENSATION (burning hot at 1 AM), FEELING ABNORMAL (looks awful), PALLOR (Pale) and PYREXIA (bad fever) outcome was unknown. Not Provided          Concomitant product use was not provided.  Treatment information was not provided.
tooth reinfection/got infected in 2018 and it was like a slow infection, started prior to the vaccine, states it was reinfected between the two doses; got infected in 2018 and it was like a slow infection, started prior to the vaccine, states it was reinfected between the two doses; fever and chills; fever and chills; This is a spontaneous report from a contactable consumer (patient) reported that:  A 78-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6202), via an intramuscular route of administration, administered in Arm Left on 25Feb2021 (At the age of 78 years) as DOSE 1, SINGLE for covid-19 immunisation. second dose was administered on18Mar2021. Medical history included thyroid cancer from 1979 to an unknown date, her thyroid was removed surgically and is on hormone replacements, root canal infection from 2018 to an unknown date, it was like a slow infection started prior to the vaccine, it was reinfected between the two doses, Car accident prior to the pandemic leading to back surgery, visual impairment since before vaccines, head and neck cancer and was a brain tumor survivor. Patient states she has had a horrible reaction to the Shingrex vaccine in the past, states she gets vaccines for everything, The patient's concomitant medications were not reported. On an unspecified date, the patient had experienced tooth reinfection, chills a nd fever. The patient stated that she will get shots in her weaker arm as she had a broken wrist and nerve damage, stated this was prior to the vaccines. The outcome of the events were unknown.   Follow-up attempts completed. No further information expected.
I swell up; got my tongue swell up; face turned like red and swelled up; face turned like red and swelled up; like I had a third degree burn on my face and burning really very bad; my arms swelled up; my arms swelled up and they did a completely red rash like red, got in rashes; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), in Mar2021 (two three weeks prior the report, as reported) at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient had BNT162b2 vaccine like two or three weeks prior the report, in Mar2021, and got home like in 2 hours later after the face turned like red and swelled up like having a third degree burn on face and burning really very bad and then 5 minutes later the arms swelled up and they did a completely red rash like red, got in rashes and they called the ambulance that gave the patient an EPIPEN and patient went to hospital in Mar2021 because of swelling up, got the tongue swell up (reason for hospitalization was not further clarified). Patient asked if it is considered an allergic reaction. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Patient came in for her flu vaccine not recalling that she received her flu vaccine for the 2022 year already back on Nov. 08 2022. Medical assistant did not verify that the pt had documentation in her chart stating she had gotten the vaccine for the year already. I called CDC, and they have informed me that the patient should not experience any adverse reaction due to being vaccinated an additional time. Only thing they noted was that the patient may experience swelling and slight pain at the injection site. Patient will be notified of the event by clinic nurse.
Knows of some people and friends that have died after receiving Moderna's COVID-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Knows of some people and friends that have died after receiving Moderna's COVID-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            Very limited information regarding this event has been provided at this time. No further follow-up information is expected.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this event has been provided at this time. No further follow-up information is expected.; Reported Cause(s) of Death: Unknown cause of death
Patient fainted after having the MCV4 vaccine administered (2nd of 6 vaccines administered).  Patient stated that she had not eaten anything in the last two hours and was very nervous about the number of vaccines that she was going to receive.  Patient was sitting on exam bed when receiving the vaccines so she was assisted by staff to lie down on the bed with her legs elevated to improve blood circulation.  Patient was administered oxygen via mask and all vitals were within normal levels (BP 110/67; pulse 58; resp 14; Oxygen 99%).  Patient and guardian agreed to complete administration of pending vaccines.  I contacted guardian at 2:48PM to check on patient and was advised that she was feeling well with no adverse effects from the incident.
Patient came to ED with chest and sinus congestion, sore throat, cough, body aches, and generalized weakness.  Patient admitted to hospital with Covid and treated with remdesivir.
is now past due for dose three of the Twinrix series; received dose two late; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 21-year-old male patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HAB (Twinrix) for prophylaxis and hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (1st dose received on 22nd November 2019).   On 8th September 2020, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, the patient received the 3rd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 8th September 2020, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device and not applicable after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the drug dose administration interval too long and incomplete course of vaccination were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows:  The age at vaccination was not applicable for 3rd dose of Twinrix. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule. Till the time of reporting patient did not receive 3rd dose of Twinrix, which led to incomplete course of vaccination. The HCP (health care professional) did not provide lot number and expiration date for dose 1 or dose 2. The reporter consent to follow up.
Pain and tingling radiating down left arm to fingertips.  Severe pain in left hand and fingers.  At times, skin on arm, especially inner aspect of upper arm, was exquisitely sensitive to touch.  Pain in upper arm sometimes accompanied by a deep burning sensation.  Symptoms appeared intermittently and increased in intensity over following days. At times, pain was almost unbearable.  Few days later, rash appeared left palm.
Swelling/redness at injection site. Fever 102.7. Headache. Required incision and drainage of soft tissue.
Experienced unspecified bad side effects with second dose (Moderna vaccine); This spontaneous case was reported by a non-health professional and describes the occurrence of IMMUNISATION REACTION (Experienced unspecified bad side effects with second dose (Moderna vaccine)) in a 35-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Patient's allergies to vaccines, medications, food, and other products were reported as unknown.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Experienced unspecified bad side effects with second dose (Moderna vaccine)). At the time of the report, IMMUNISATION REACTION (Experienced unspecified bad side effects with second dose (Moderna vaccine)) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Pfizer was taken as 1st Booster Dose. Patient experienced bad side effects after booster.  No treatment medication was provided.
I developed a fever, sore arm and extreme fatigue.  On day two I developed a sore throat and it hurt to swallow.  On day three, my lymph nodes were extremely swollen.  I called out of work at 5am, slept until noon to go to urgent care where they confirmed swollen lymph nodes and gave me a steroid to help with the pain.  I went back home and went back to sleep for the rest of the day and night.
2 weeks after my booster, I broke out in a rash/hive like streaks all over my body.  These red streaks will last for about 15 minutes and then will disappear and reappear on another spot on my body.  Slightly itchy but not unbearable.
Mother reports patient stiffened for 5 seconds, arched her back and head turn right. Patient cried after, EMS called vitals were normal, no fever and not transported. Patient had a follow up visit with provider today to ensure neurological status intact. No further signs or symptoms occurred or reported after the one time event. Father reports they thought she had seizure at 11 mo old and had fever the day prior. None since.
Extreme tired and groggy, rash started by injection site and expanded along arm- welted, itchy, and warm to touch. Lasted 3 days.
she developed bicipital tendinitis in her left arm; This is a spontaneous report received from contactable reporter (Consumer) from medical information team, Program ID. The reporter is the patient.  A 72-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2021 as dose 3 (booster), single (Lot number: EW0186), on 24Jun2022 as dose 4 (booster), single (Lot number: FM7553) and on 25Sep2022 as dose 5 (booster), single (Lot number: GH9703) at the age of 71 years for covid-19 immunisation. The patient's relevant medical history included: "She has a history of osteoarthritis in her left shoulder", start date: 2004 (ongoing), notes: Bone on Bone Osteoarthritis; "Inflammatory arthritis", start date: 2019 (ongoing). There were no concomitant medications. Vaccination history included: bnt162b2 (Dose 1, Lot: EL3249, Primary Immunization series completed.), administration date: 21Jan2021, for Covid-19 Immunization, reaction(s): "had surgery in Mar2022 and had 3 lymph nodes removed", "After her covid primary series, she developed breast cancer"; bnt162b2 (Dose 2, Lot: EL8982, Primary Immunization series completed.), administration date: 11Feb2021, for Covid-19 Immunization, reaction(s): "had surgery in Mar2022 and had 3 lymph nodes removed", "After her covid primary series, she developed breast cancer". The following information was reported: TENDONITIS (non-serious) with onset Sep2022, outcome "recovering", described as "she developed bicipital tendinitis in her left arm".  Additional information: Inquiry: Patient wanted to know if she can inject the Pfizer covid 19 vaccines anywhere other than shoulder or muscles. After her last booster in Sep2022, she developed bicipital tendinitis in her left arm. She has a history of osteoarthritis in her left shoulder and last week, had a steroid shot in her shoulder joint.
"I did not have any issues with the first vaccine. The second vaccine I ran a fever for approximately 24 hours and it was as high as 102.4*F. I also experienced joint ached and muscle ache for about 18 hours, hallucinations for about 6 hours and  now I have a rash on my lower back."
1 day p/vax pt devel an inj site rxn characterized by redness & swelling the size of a fruit jar lid;also felt flushed;
After being administered the Shingrix shot, coughing started 4 hours later. Coughing lasted 3 hours. This led to vomiting. Vomiting continued for 10 continuous hours. Admitted to ED for extreme dehydration due to vomiting. 2+ liters of fluid administered. along with medication to settle the stomach and medication for pain. 5 hour hospital ED visit.
NUMBNESS IN LEFT WRISTS WHICH MOVES TOWARDS LEFT  HAND; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on left arm on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced numbness in left wrists which moves towards left hand. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of numbness in left wrists which moves towards left hand was not reported. This report was non-serious.